Athyrium Opportunities Fund (a) Lp - Net Worth and Insider Trading
Athyrium Opportunities Fund (a) Lp Net Worth
The estimated net worth of Athyrium Opportunities Fund (a) Lp is at least $382,896 dollars as of 2024-11-13. Athyrium Opportunities Fund (a) Lp is the 10% Owner of Biora Therapeutics Inc and owns about 145,588 shares of Biora Therapeutics Inc (BIOR) stock worth over $382,896. Details can be seen in Athyrium Opportunities Fund (a) Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Athyrium Opportunities Fund (a) Lp has not made any transactions after 2021-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Athyrium Opportunities Fund (a) Lp
Athyrium Opportunities Fund (a) Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Athyrium Opportunities Fund (a) Lp owns 1 companies in total, including Biora Therapeutics Inc (BIOR) .
Insider Ownership Summary of Athyrium Opportunities Fund (a) Lp
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BIOR | Biora Therapeutics Inc | 2021-06-14 | 10 percent owner |
Athyrium Opportunities Fund (a) Lp Latest Holdings Summary
Athyrium Opportunities Fund (a) Lp currently owns a total of 1 stock. Athyrium Opportunities Fund (a) Lp owns 145,588 shares of Biora Therapeutics Inc (BIOR) as of June 14, 2021, with a value of $382,896.
Latest Holdings of Athyrium Opportunities Fund (a) Lp
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BIOR | Biora Therapeutics Inc | 2021-06-14 | 145,588 | 2.63 | 382,896 |
Holding Weightings of Athyrium Opportunities Fund (a) Lp
Athyrium Opportunities Fund (a) Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Athyrium Opportunities Fund (a) Lp has made a total of 3 transactions in Biora Therapeutics Inc (BIOR) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Biora Therapeutics Inc is the acquisition of 32,389 shares on June 14, 2021, which cost Athyrium Opportunities Fund (a) Lp around $20 Million.
Insider Trading History of Athyrium Opportunities Fund (a) Lp
- 1
Athyrium Opportunities Fund (a) Lp Trading Performance
GuruFocus tracks the stock performance after each of Athyrium Opportunities Fund (a) Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Athyrium Opportunities Fund (a) Lp is -25.58%. GuruFocus also compares Athyrium Opportunities Fund (a) Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Athyrium Opportunities Fund (a) Lp within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Athyrium Opportunities Fund (a) Lp's insider trading performs compared to the benchmark.
Performance of Athyrium Opportunities Fund (a) Lp
Athyrium Opportunities Fund (a) Lp Ownership Network
Ownership Network List of Athyrium Opportunities Fund (a) Lp
Ownership Network Relation of Athyrium Opportunities Fund (a) Lp
Athyrium Opportunities Fund (a) Lp Owned Company Details
What does Biora Therapeutics Inc do?
Who are the key executives at Biora Therapeutics Inc?
Athyrium Opportunities Fund (a) Lp is the 10 percent owner of Biora Therapeutics Inc. Other key executives at Biora Therapeutics Inc include 10 percent owner Athyrium Opportunities Iii Co-invest 1 Lp , director & Chief Executive Officer Aditya P. Mohanty , and 10 percent owner Athyrium Capital Management, Lp .
Biora Therapeutics Inc (BIOR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biora Therapeutics Inc (BIOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biora Therapeutics Inc (BIOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biora Therapeutics Inc (BIOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biora Therapeutics Inc Insider Transactions
Athyrium Opportunities Fund (a) Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Athyrium Opportunities Fund (a) Lp. You might contact Athyrium Opportunities Fund (a) Lp via mailing address: 605 Third Avenue, 22nd Floor, New York Ny 10158.